6649.TWO Taiwan Biomaterial Co., Ltd.

Healthcare Medical Devices Taiwan OTC Exchange
34.50 TWD
Close of Nov 6, 2026
33.00 52.75
Market cap
TWD 1.45B
P/E
43.7x
P/B
2.39x
ROE
0.2%
Dividend yield
2.74%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6649.TWO undervalued?

Graham number
Price34.50
Graham value16.03
Premium115.3%

6649.TWO trades 115.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Taiwan Biomaterial Co., Ltd. fundamental analysis

No fundamental analysis for Taiwan Biomaterial Co., Ltd. yet.

Taiwan Biomaterial Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Taiwan Biomaterial Co., Ltd.

Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan. It provides Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO. The company…

Full company profile